• The development project involves investment of $40M and doubled its production capacity and will export biosimilar in Central America- South America- Africa- Asia and the Middle East
• The plant will currently have 162 employees with 50 new jobs- and it is expected to generate another 50 positions over the coming years work according to GMP
• The company will own now three biosimilar plants two in Argentina and one in Spain (León)

Click here to read full press release/ article | Ref: mAbxience | Image: Twitter